日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of a universal preprocedural screening program for coronavirus disease 2019 (COVID-19)

对一项普遍适用的冠状病毒病 2019 (COVID-19) 术前筛查计划的评估

Dbeibo, Lana; Kuebler, Kari; Keen, Alyson; George, Annie; Kelley, Kristen; Sadowski, Josh; Basham, Laura; Beeson, Terrie; Schmidt, C Max; Beeler, Cole; Webb, Douglas

Clinical comparison and agreement of PCR, antigen, and viral culture for the diagnosis of COVID-19: Clinical Agreement Between Diagnostics for COVID19

COVID-19诊断中PCR、抗原和病毒培养的临床比较和一致性:COVID-19诊断方法之间的临床一致性

Agard, Amanda; Elsheikh, Omar; Bell, Drew; Relich, Ryan F; Schmitt, Bryan H; Sadowski, Josh; Fadel, William; Webb, Douglas H; Dbeibo, Lana; Kelley, Kristen; Carozza, Mariel; Lei, Guang-Shen; Calkins, Paul; Beeler, Cole

Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19

新冠肺炎住院成人患者的临床特征、结局和预后因素

Gavin, Warren; Campbell, Elliott; Zaidi, Syed-Adeel; Gavin, Neha; Dbeibo, Lana; Beeler, Cole; Kuebler, Kari; Abdel-Rahman, Ahmed; Luetkemeyer, Mark; Kara, Areeba

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure

不同程度接触2019冠状病毒病(COVID-19)患者的医护人员中严重急性呼吸道冠状病毒2(SARS-CoV-2)抗体的血清阳性率

Hunter, Benton R; Dbeibo, Lana; Weaver, Christopher S; Beeler, Cole; Saysana, Michele; Zimmerman, Michelle K; Weaver, Lindsay

Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

评估 CpxRA 作为泌尿道致病性大肠杆菌感染的治疗靶点

Dbeibo Lana, van Rensburg Julia J, Smith Sara N, Fortney Kate R, Gangaiah Dharanesh, Gao Hongyu, Marzoa Juan, Liu Yunlong, Mobley Harry L T, Spinola Stanley M